Literature DB >> 6361554

The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients with Type I diabetes mellitus.

P Raskin, A O Pietri, R Unger, W A Shannon.   

Abstract

We studied the relation between the control of blood glucose and the width of skeletal-muscle capillary basement membrane in 23 insulin-dependent (Type I) diabetic patients. After initial measurement of levels of glycosylated hemoglobin and width of skeletal-muscle capillary basement membrane, the patients were divided into two groups: an experimental group of 13 patients who were treated with continuous subcutaneous insulin infusion, and a control group of 10 patients who continued to receive conventional treatment--usually two injections of insulin daily. After two years, the experimental group had a significant decrease in glycosylated hemoglobin levels as compared with base-line values (mean +/- S.E.M., 7.6 +/- 0.4 vs 10.2 +/- 0.7 per cent; P less than 0.001), reflecting improved control of blood glucose, and a significant reduction in the width of skeletal-muscle capillary basement membrane (1293 +/- 68 vs. 1717 +/- 182 A; P less than 0.05). The control group of patients had no significant change in their levels of glycosylated hemoglobin or in the width of their skeletal-muscle capillary basement membranes. If changes in the capillaries in skeletal muscle parallel those in the capillaries in retinal or renal tissue, then meticulous control of blood glucose may be beneficial over time in preventing the microvascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361554     DOI: 10.1056/NEJM198312223092504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Controlling blood sugars.

Authors:  A Mehta; I Matwijiw
Journal:  Can Fam Physician       Date:  1985-07       Impact factor: 3.275

2.  The insulin pump.

Authors:  C J Toews
Journal:  Can Fam Physician       Date:  1985-07       Impact factor: 3.275

3.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

4.  Hyperglycemia and the pathogenesis of diabetic retinopathy.

Authors:  G L King
Journal:  J Gen Intern Med       Date:  1986 Mar-Apr       Impact factor: 5.128

Review 5.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 6.  Feedback control methods for drug dosage optimisation. Concepts, classification and clinical application.

Authors:  S Vozeh; J L Steimer
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

7.  Management of diabetes mellitus.

Authors:  M B Davidson
Journal:  West J Med       Date:  1984-03

8.  Arrest of glomerulopathy in diabetic dogs by improved glycaemic control.

Authors:  T S Kern; R L Engerman
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

9.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Erythrocyte adhesion to cultured endothelium and glycaemic control in type 1 (insulin-dependent) diabetic patients.

Authors:  J L Wautier; H LeBlanc; M P Wautier; E Abadie; P Passa; J P Caen
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.